Novartis
NVS
NVS
1,005 hedge funds and large institutions have $21.1B invested in Novartis in 2017 Q4 according to their latest regulatory filings, with 137 funds opening new positions, 344 increasing their positions, 334 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.31% less ownership
Funds ownership: 11.03% → 10.72% (-0.31%)
5% less capital invested
Capital invested by funds: $22.2B → $21.1B (-$1.08B)
37% less funds holding in top 10
Funds holding in top 10: 38 → 24 (-14)
Holders
1,005
Holding in Top 10
24
Calls
$61.9M
Puts
$42.2M
Top Buyers
| 1 | +$46.9M | |
| 2 | +$34.1M | |
| 3 | +$25.6M | |
| 4 |
Morgan Stanley
New York
|
+$25.3M |
| 5 |
Renaissance Technologies
New York
|
+$22.8M |
Top Sellers
| 1 | -$282M | |
| 2 | -$155M | |
| 3 | -$92.2M | |
| 4 |
SCM
Sterling Capital Management
Charlotte,
North Carolina
|
-$74.7M |
| 5 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$73.8M |